Rare diseases
Investigational molecules
Locations
Back to Germany1 140 clinical trials in Hamburg, Germany across 19 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effectiveness of Survodutide for Weight Loss in Patients with Type 2 Diabetes and Obesity
GermanyStudy on the Effectiveness of Survodutide for Weight Loss in Adults with Obesity Without Diabetes
GermanyTitle: Study of Sibeprenlimab Treatment for Adults with Sjögren's Disease Using Subcutaneous Injections
GermanyStudy Comparing Belantamab Mafodotin with Lenalidomide and Dexamethasone to Daratumumab with Lenalidomide and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma
GermanyStudy on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Atopic Dermatitis
GermanyStudy on How Cagrilintide and Semaglutide Help People with Overweight or Obesity Reduce Weight
GermanyStudy of pacritinib effectiveness and safety compared to placebo in patients with VEXAS syndrome
GermanyStudy of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment
GermanyStudy on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps
GermanyStudy on ABBV-400, Fluorouracil, Leucovorin, and Budigalimab for Advanced or Metastatic Stomach and Esophageal Cancer Patients
GermanyStudy of AZD9550 and AZD6234 combination for weight loss in people with obesity or overweight with health complications
GermanyStudy of local treatment options for large metastases in patients with BRAF V600 mutated melanoma receiving encorafenib and binimetinib combination therapy
GermanyThe busiest research cities in the country
What the registry says about research in the country
Current clinical trials focusing on innovative treatments for metastatic prostate cancer, colorectal cancer, and breast cancer. Studies are evaluating new therapeutic combinations and targeted approaches for improved patient outcomes.
Comprehensive vaccine development programs targeting respiratory syncytial virus, cytomegalovirus, and meningococcal infections. Research focuses on both adult and pediatric populations.
Groundbreaking research in treating acute cerebral ischemic stroke with innovative therapies. Studies are evaluating functional outcomes and safety profiles of new therapeutic agents.
Clinical investigations addressing vaginal atrophy and contraceptive technologies. Research includes novel delivery systems and hormone-based treatments for postmenopausal conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
